DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Antiacne Medications Pseudotumor Cerebri

Information source: University of Zurich
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Optic Disc Swelling

Intervention: Retinal nerve fibre layer measurement (Other)

Phase: Phase 4

Status: Recruiting

Sponsored by: University of Zurich

Official(s) and/or principal investigator(s):
Klara Landau, Prof MD, Study Chair, Affiliation: UniversityHospital, Zurich

Overall contact:
Gregor Jaggi, MD, Phone: 0041 44 255 49 00, Email: gregor.jaggi@usz.ch

Summary

The exact incidence of optic disc swelling and idiopathic intracranial hypertension in patients using antiacne medication is not known so far. The investigators hypothesize that swelling of retinal nerve fibre layer measured by optical coherence tomography is more frequent then assumed so far.

Clinical Details

Official title: Prospective Open-label Phase IV Trial to Investigate the Frequency of Optic Disc Swelling, Idiopathic Intracranial Hypertension and Dry Eye Symptoms Under Antiacne Medication Treatment

Study design: Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Retinal nerve fibre layer

Detailed description: Measurement of retinal nerve fibre layer using optical coherence tomography over a period of 6 to 9 months depending on exact antiacne medication.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Antiacne medication treatment indicated by dermatologist

- age > 18 years

- contraception if indicated

Exclusion Criteria:

- age < 18 years

Locations and Contacts

Gregor Jaggi, MD, Phone: 0041 44 255 49 00, Email: gregor.jaggi@usz.ch

University Hospital Zurich, Zurich, ZH 8091, Switzerland; Recruiting
Isabelle Meneau, Email: isabelle.meneau@usz.ch
Gregor Jaggi, MD, Principal Investigator
Additional Information

Study register Switzerland

Starting date: April 2014
Last updated: May 26, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017